Q4 2024 · 13F-HR
Madison Avenue Partners, LPholdings as filed
Filed 2025-02-14 · accession 0001801265-25-000002
$944.4M
Reported value
15
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 384637104 | GHC | GRAHAM HLDGS CO | $205.1M | 21.7% | 235,271 | Common | SOLE |
| 83444M101 | SOLV | SOLVENTUM CORP | $186.8M | 19.8% | 2,827,672 | Common | SOLE |
| 968223206 | WLY | WILEY JOHN & SONS INC | $91.7M | 9.70% | 2,096,793 | Common | SOLE |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $89.5M | 9.48% | 9,511,150 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY INC | $76.3M | 8.08% | 1,925,327 | Common | SOLE |
| 29260Y109 | 0C3 | ENDEAVOR GROUP HLDGS INC | $75.0M | 7.94% | 2,397,658 | Common | SOLE |
| 55939A107 | MAGN | MAGNERA CORP | $61.9M | 6.55% | 3,406,293 | Common | SOLE |
| 85256A109 | STGW | STAGWELL INC | $47.0M | 4.98% | 7,147,662 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $45.7M | 4.84% | 3,673,426 | Common | SOLE |
| 64031N108 | NNI | NELNET INC | $31.0M | 3.28% | 290,213 | Common | SOLE |
| 457651107 | INVX | INNOVEX INTERNATIONAL INC | $23.6M | 2.49% | 1,686,476 | Common | SOLE |
| 35471R106 | FSP | FRANKLIN STR PPTYS CORP | $5.0M | 0.53% | 2,733,418 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $3.5M | 0.37% | 3,722,627 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $1.7M | 0.18% | 579,895 | Common | SOLE |
| G8068L108 | SN | SHARKNINJA INC | $598,959 | 0.06% | 6,152 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.